fda semaglutide compounding enforcement october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Out of Shortage, Into Controversy:

Given that the GLP1 receptor is expressed on all four chambers of the heart as well as the sinoatrial node, it is likely that GLP1 and its mimetics exert a direct action on cardiac cells (Baggio et al., 2018)

In another animal study, ashwagandha reversed paclitaxel-induced neutropenia in mice when administered for four days before paclitaxel treatment and continued for 12 days after treatment

A comprehensive and age-specific behavioral assessment battery utilizing a total of eight different tests was used to assess which core areas of ASD could be impacted by this intervention

Unlike traditional ED medications that primarily increase blood flow to the penis, PT-141 takes a different approach: Brain-Centered Action: PT-141, a synthetic hormone, works at the source of desire: the mind

The usable window is 3 to 7 days when stored at 2 to 8C